Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

FDA approves first vaccine for respiratory syncytial virus

The FDA has approved the first vaccine for respiratory syncytial virus (RSV).

The Hindu

Delta-8 THC May Have Untapped Disease-Fighting Potential

There are still many unknowns, but we see great promise in these products in medical applications.

Inverse

Abortion pill legal challenge threatens miscarriage care

One of the most widely used treatments for miscarriage is in jeopardy

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Everything you need to know about sunscreen ingredients—including which ones to look for and which to avoid

Experts share the potential sunscreen ingredients to avoid, plus, the reef-safe sunscreen ingredients to know about

My Imperfect Life

Attorneys General Call for Medicare to End Restrictions on Alzheimer’s Disease Treatments

While there is no known cure for Alzheimer’s disease, there are promising — but expensive — treatments.

Kiplinger

FDA weighing 1st over-the-counter birth control pill

U.S. health regulators are weighing the first-ever request to make a birth control pill available without a prescription

The Independent UK

FDA approves 1st RSV vaccine for older adults

After decades of failure in the quest for an RSV vaccine, doctors are anxious to finally have something to offer — especially after a virus surge that strained hospitals last fall.

Chicago Sun-Times

Read news from The Economist, FT, and more,
with one subscription

FDA approves 1st RSV vaccine

The Food and Drug Administration has approved a vaccine for respiratory syncytial virus (RSV) for use in people ages 60 and older.

LiveScience

One of the cheapest diabetes drugs on the market can also slow aging and extend your life span. Here's how

Metformin costs pennies a day, is safe, and has been scientifically shown to impact age-related biological changes.

Fortune

World's first respiratory syncytial virus vaccine gets approval: Key points to know

Pharmaceutical company GSK's RSV vaccine has been approved by the US Food and Drug Administration (FDA) to become the world's first such vaccine. Known as Arexvy, this vaccine has been approved after three clinical trials.

The Times of India

Smelling salt products promise an 'energy boost,' but have reportedly caused seizures, FDA warns

The Food and Drug Administration warned that unapproved inhalant products containing ammonia may pose health risks.

LiveScience

FDA approves United States' first-ever RSV vaccine

GSK's RSV vaccine is approved for people aged 60 and older.

Axios

US approves first vaccine for RSV after decades of attempts

The US has approved the first vaccine for RSV, shots to protect older adults

The Independent UK

It's OK To Let People Take Risks for Medical Science

A recent study finds that human challenge trials are largely safe.

Reason

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

We can't keep up with COVID's mutations

The FDA is allowing additional bivalent shots — but a new study suggests they don't work as well as they used to

WEKU

Gene therapy for muscular dystrophy stirs hopes and controversy

The FDA is considering greenlighting the experimental treatment under its accelerated approvals program. Some critics point out the therapy isn't yet proven to work and may be costly.

Marie Claire

Dermatologists Talk Daxxify, the Newest Player on the Neuromodulator Scene

Daxxify claims to last twice as long as its competitors—but is that true?

TechRadar

DNA sequencing platform hit by serious security flaws

One of the two vulnerabilities discovered carries a 10/10 severity score.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Can drugs fix the UK’s adolescent obesity crisis?

A powerful new weight-loss medication may be approved for those aged 12 to 17. But healthcare professionals fear it ignores the underlying socioeconomic causes

Inverse

The Former Pro Athletes Turning to Magic Mushrooms for Relief

The use of psychedelic mushrooms is gaining traction in the United States. Many researchers predict FDA approval of a psychedelic treatment will come within the next five years.

The Hindu

Explained | Can psychedelics treat depression? A doctor explains.

Can psychedelic drugs create lasting positive changes in brain function? The Hindu explains the potential benefits of their use in treating depression. Subscribe now to read the full article.

Salon

Hepatitis A outbreak worsens

You may want to skip the frozen fruits section at your grocery store until the recent recalls have been lifted

The Conversation

Cannabis-derived products like delta-8 THC and delta-10 THC have flooded the US market – two immunologists explain the medicinal benefits and potential risks

These days you see signs for delta-8 THC, delta-10 THC and CBD, or cannabidiol, everywhere – at gas stations, convenience stores, vape shops and online. Many people are rightly wondering which of these compounds are legal, whether it is safe to consume them and which of their supposed medicinal benefits…

LiveScience

FDA approves 1st pill made from human poop

The Food and Drug Administration approved the second-ever medical treatment made from donated human feces.

The Independent UK

Vermont passes bills aimed at protecting abortion pills

The Vermont Legislature has passed reproductive and gender-affirming health care bills with a late addition aimed at protecting access to a medication widely used in abortions — even if the U.S. Food and Drug Administration withdraws its approval of mifepristone

1 … 131 132 133 134

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

336 stories

The National Institutes of Health

150 stories

Illumina

80 stories

the US Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.